Csl Limited has released a press release.
CSL Results Presentation for FY2026
Earlier from Csl
- CSL: European Commission (EC) adopts decision to revoke marketing authorisation for TAVNEOS® (avacopan) in the European Union and European Economic Area countries
- CSL Marks the Completion of the First Vessel in World-Leading Transhipment Fleet for Simandou Project
- CSL Reports Positive Top-Line Phase 3b Results Supporting Planned Expanded Pediatric Filing for ANDEMBRY® (garadacimab-gxii) in Children with Hereditary Angioedema (HAE)
- CSL Delivers World’s First Battery-Powered Self-Unloading Bulk Carrier to Support Adbri Operations